Market Research Reports

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

  The global surgical robotics market is anticipated to witness tremendous growth over the forecast period primarily due to the increasing prevalence rate of chronic disorders, growing global population coupled with the geriatric population, improving reimbursement policies, and public initiatives and funding to develop technologically advanced products. Surgical robotic systems primarily include surgical systems (capital equipment), instruments and accessories (consumables), and services (maintenance and up-gradation).  In the past decade, the definition of these advanced technologies has expanded, involving the use of these systems for multiple surgical procedures ranging from general surgeries to orthopedic surgeries. The ongoing trend of rising demand for surgical robotic systems is anticipated to continue in the future with the implementation of technological innovations and advancements in minimally invasive surgical procedures.  The global surgical robotics market was

  The market for cell-free RNA isolation and extraction kits is substantial and plays a crucial role in the gathering of data for a variety of treatment strategies, underscoring its importance in the healthcare industry. Since it ensures the safe and efficient use of targeted therapies, cell-free RNA is essential to the precision medicine approach. The majority of market participants in the global market for cell-free RNA isolation and extraction kits offer goods that include the kits. The global  cell-free RNA isolation and extraction kits market   is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis. Impact •   The presence of major products of cell-free RNA isolation and ext

  The global healthcare industry is expected to significantly benefit from the growth in the adoption of big data technologies. The advantages of the technology are immense and proven. Future growth is expected to be driven by more countries and their healthcare systems going digital and focusing on data-driven healthcare. The healthcare industry is expected to be significantly boosted by the growing demand for evidence-based clinical care in developing countries. Technological advancements anticipated from 2022 to 2031 are expected to play a crucial role in deciding the future of big data in healthcare market and the level of adoption. Currently, the market growth is hampered by a large volume of unstructured data, slow pace of adoption of digital health in some emerging countries, and lack of sufficient rules and regulations to support mass adoption in emerging countries. The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to

  The global FLT3 inhibitors market is in the growing stage. The landscape of treatment of blood cancers with FLT3 positive mutations by novel inhibitory therapeutics is massively growing, with many emerging and legacy companies venturing into the industry with their respective therapeutic portfolio exclusively developed and designed for the treatment of FLT3 mutated acute myeloid leukemia (AML). Through imaging, genetic, and biomarker studies, researchers are gaining a deeper understanding of the biology of AML, which will likely resolve many current problems in FLT3 mutated AML diagnosis and classification. The global  FLT3 inhibitors market  is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the introduction of novel products, the increasing incidence of acute myeloid leukemia, and the rising research and development investments, amo

  Next-generation sequencing (NGS) provides sequence profiling from transcriptomes and genome to deoxyribonucleic acid (DNA)-protein interactions. The technologies used in the workflow of sequencing are an integral part of research and discovery in biology.  The increasing number of new cancer cases across the globe, favorable regulatory and reimbursement scenarios for NGS-based tests in the U.S. and increasing focus of key market players on developing NGS-based products for cancer and noninvasive prenatal testing (NIPT). Moreover, next-generation sequencing techniques are widely used for the diagnosis of genetic diseases. The increasingly widespread use of NGS in diagnostic laboratories has enhanced the accuracy of genetic diagnostics with high consistency. As per BIS Research analysis the NGS sample preparation market is expected to witness robust growth. The market growth for NGS sample preparation is attributed to the use of NGS sample preparation in medical science, which has

The global pharmacogenomics services market is expected to witness high growth, attributing to the global increase in the prevalence of infectious diseases and various types of cancers, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, rise in the rate of adverse drug reactions, and surge in the usage of pharmacogenomics for drug discovery and development. The continued significant investments by the emerging and legacy companies to meet industry demand and the growth in biomarker discovery are major factors propelling the growth of the global pharmacogenomics services market. The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. To gain a holistic view of the market, data from different segments of the market has been analyzed minutely These segments include types of services (genotyping, SNP identification,

Operating  Room (OR) integration connects technology, information, and personnel throughout the hospital to create a purpose-built system that reduces the dependency on mobile equipment. The global operating room (OR) integration market is a huge market comprising various product types that are used in an operating room. These include products for visualization, lighting, imaging, OR integration software, and other products such as insufflators, medical printing devices, and OR communication and control systems. The major factors driving growth include increased adoption of minimally invasive procedures, rising geriatric population escalating surgical needs, increasing demand to streamline surgical workflow, the shift of TAVI procedures to the integrated environment, and increasing patients’ safety concerns in the OR. The global OR integration systems market was valued at $11,763.6 million in 2021 and is anticipated to grow to $21,546.1 million by the end of 2031 at a projec

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on several markets. Hype